HomeComparePFE vs PXD

PFE vs PXD: Dividend Comparison 2026

PFE yields 6.20% · PXD yields 4.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXD wins by $1950.77M in total portfolio value
10 years
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →
PXD
PXD
● Live price
4.06%
Share price
$269.62
Annual div
$10.94
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1950.82M
Annual income
$1,862,635,547.63
Full PXD calculator →

Portfolio growth — PFE vs PXD

📍 PXD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFEPXD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFE + PXD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFE pays
PXD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
PXD
Annual income on $10K today (after 15% tax)
$344.89/yr
After 10yr DRIP, annual income (after tax)
$1,583,240,215.49/yr
At 15% tax rate, PXD beats the other by $1,583,217,086.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFE + PXD for your $10,000?

PFE: 50%PXD: 50%
100% PXD50/50100% PFE
Portfolio after 10yr
$975.44M
Annual income
$931,331,379.09/yr
Blended yield
95.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PXD right now

PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
PXD
Analyst Ratings
43
Buy
24
Hold
3
Sell
Consensus: Buy
Price Target
$254.09
-5.8% upside vs current
Range: $196.00 — $347.00
Altman Z
4.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFE buys
0
PXD buys
0
No recent congressional trades found for PFE or PXD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFEPXD
Forward yield6.20%4.06%
Annual dividend / share$1.72$10.94
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.2%100%
Portfolio after 10y$51.1K$1950.82M
Annual income after 10y$27,210.54$1,862,635,547.63
Total dividends collected$60.1K$1944.52M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldBuy
Analyst price target$27.50$254.09

Year-by-year: PFE vs PXD ($10,000, DRIP)

YearPFE PortfolioPFE Income/yrPXD PortfolioPXD Income/yrGap
1← crossover$9,161$701.38$11,512$811.51$2.4KPXD
2$8,610$859.79$14,063$1,746.12$5.5KPXD
3$8,366$1,081.25$19,035$3,987.30$10.7KPXD
4$8,483$1,405.66$30,455$10,087.67$22.0KPXD
5$9,084$1,907.24$62,755$30,167.77$53.7KPXD
6$10,418$2,732.78$183,339$116,191.48$172.9KPXD
7$13,007$4,193.56$830,668$634,494.75$817.7KPXD
8$18,010$7,005.87$6,262,177$5,373,362.05$6.24MPXD
9$28,216$12,979.89$82,416,983$75,716,453.96$82.39MPXD
10$51,081$27,210.54$1,950,821,719$1,862,635,547.63$1950.77MPXD

PFE vs PXD: Complete Analysis 2026

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →

PXDStock

Pioneer Natural Resources Company operates as an independent oil and gas exploration and production company in the United States. The company explores for, develops, and produces oil, natural gas liquids (NGLs), and gas. It has operations in the Midland Basin in West Texas. As of December 31, 2021, the company had proved undeveloped reserves and proved developed non-producing reserves of 130 million barrels of oil, 92 million barrels of NGLs, and 462 billion cubic feet of gas; and owned interests in 11 gas processing plants. Pioneer Natural Resources Company was founded in 1997 and is headquartered in Irving, Texas.

Full PXD Calculator →
📬

Get this PFE vs PXD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFE vs JNJPFE vs MRKPFE vs ABBVPFE vs BMYPFE vs LLYPFE vs SCHDPFE vs JEPIPFE vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.